HECA

FDA Proposes Simplified Registration for Distributed Drug Manufacturers

by

The U.S. Food and Drug Administration (FDA) has proposed a new regulatory framework designed to modernize how distributed pharmaceutical manufacturing sites register with the agency. Under the proposal, companies utilizing a “hub-and-spoke” manufacturing model—where a central location oversees multiple production units—would be permitted to register as a single establishment. The rule also mandates tighter reporting … Read more

FDA to Review Sandoz Generic GLP-1s

by

The U.S. Food and Drug Administration (FDA) has officially accepted for review Sandoz’s applications for two generic versions of tirzepatide, the active ingredient in Eli Lilly’s popular weight-loss and diabetes treatments. This regulatory step marks a significant move toward potential market competition for Mounjaro and Zepbound ahead of the expiration of Eli Lilly’s U.S. patents … Read more

Roche Challenges Illumina with New Axelios Gene Sequencer

by

Roche has launched its Axelios gene sequencer, a new platform designed to perform large-scale DNA and RNA analysis, marking the company’s attempt to compete with industry leader Illumina. Roche aims to sell about 100 machines within the first year, targeting academic and research institutions to build a foundation for long-term growth in the $7.3 billion … Read more

Smart Tech Protecting Rome’s Elderly During Heatwaves

by

Wearable health technology is increasingly serving as a critical safety net for elderly populations in Europe, as evidenced by a Rome-based pilot program using biometric monitoring bracelets. According to Reuters, the €400-million ($456 million) initiative supports approximately 700 residents by tracking vital signs, sleep patterns, and fall detection to provide immediate emergency response during extreme … Read more

Merck to Acquire Bio-Techne in $11 Billion Life Sciences Deal

by

Merck KGaA has announced an $11.3 billion agreement to acquire U.S.-based Bio-Techne, marking the German pharmaceutical giant’s largest acquisition since 2014. The deal, which offers $73 per share—a 24% premium over the closing price on Wednesday—is designed to bolster Merck’s life sciences division by integrating Bio-Techne’s extensive portfolio of research reagents, proteins, and analytical instruments … Read more

Ebola Bundibugyo Outbreak: Why Knowledge Gaps Hinder Response

by

The Ebola Bundibugyo outbreak in the Democratic Republic of Congo has reached over 1,100 confirmed cases and nearly 300 deaths, according to government reports. Health officials, including the World Health Organization (WHO), state that a lack of diagnostic tools, limited clinical data, and community mistrust regarding the virus’s atypical symptoms are currently hindering containment efforts … Read more

US Deploys Ebola Treatments to Congo for Clinical Trials

by

The U.S. government has begun shipping stockpiled doses of an experimental antibody drug, MBP134, from Mapp Biopharmaceutical to the Democratic Republic of Congo to combat a widening Bundibugyo Ebola outbreak. According to the U.S. Department of Health and Human Services, this shift in policy marks the first time Washington has released the treatment for clinical … Read more

European Patients Face Increasing Barriers to Access New Medications

by

Why Patient Access to New Medicines is Worsening Across Europe Patient access to new medicines in Europe is deteriorating, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), which released research highlighting a 597-day average delay between drug approval and patient availability—up from 504 days in 2019. The study, conducted by Germany’s WifOR … Read more

California Sues EPA Over Attempt to Reverse Emissions Rules

by

The state of California has filed a lawsuit against the U.S. Environmental Protection Agency (EPA) to block an attempt to repeal long-standing vehicle emissions waivers. The EPA recently sent these waivers to Congress for potential revocation under the Congressional Review Act, a move California Attorney General Rob Bonta describes as an illegal effort to undermine … Read more

Sri Lanka Faces Dengue Surge With Over 44,000 Cases

by

Sri Lanka is currently managing a major outbreak of mosquito-borne dengue fever, recording over 44,000 cases and 28 deaths since January 2026. According to the National Dengue Control Unit (NDCU), the surge is linked to post-cyclone environmental debris providing new breeding grounds, with public health officials warning that hospitals face severe strain as infection rates … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]